2,899
Views
3
CrossRef citations to date
0
Altmetric
Articles

Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance

, , , &
Article: 1270080 | Received 20 Aug 2016, Accepted 26 Nov 2016, Published online: 19 Jan 2017

References

  • James JJ, Evans AJ, Pinder SE, et al. Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features. Br J Cancer. 2003;89:1–7. DOI:10.1038/sj.bjc.6601198
  • Li BT, Wong MH, Pavlakis N. Treatment and prevention of bone metastases from breast cancer: A comprehensive review of evidence for clinical practice. J Clin Med. 2014;3:1–24. DOI:10.3390/jcm3010001
  • Durán I, Garzón C, Sánchez A, et al. Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours. Clin Transl Oncol. 2014;16:322–329. DOI:10.1007/s12094-013-1077-2
  • Feyer PC, Steingraeber M. Radiotherapy of bone metastasis in breast cancer patients - Current approaches. Breast Care (Basel). 2012;7:108–112. DOI:10.1159/000338724
  • Jensen AØ, Jacobsen JB, Nørgaard M, et al. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer. 2011;11:29. DOI:10.1186/1471-2407-11-29
  • Yong M, Jensen AÖ, Jacobsen JB, et al. Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999-2007). Breast Cancer Res Treat. 2011;129:495–503. DOI:10.1007/s10549-011-1475-5
  • Wu JS, Wong R, Johnston M, et al. Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys. 2003;55:594–605.
  • Chow E, Zeng L, Salvo N, et al. Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol (R Coll Radiol). 2012;24:112–124. DOI:10.1016/j.clon.2011.11.004
  • Rasmusson B, Vejborg I, Jensen AB, et al. Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiother Oncol. 1995;34:179–184.
  • Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97:798–804. DOI:10.1093/jnci/dji139
  • van der Linden YM, Steenland E, van Houwelingen HC, et al. Dutch Bone Metastasis Study Group: Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study. Radiother Oncol. 2006;78:245–253. DOI:10.1016/j.radonc.2006.02.007
  • Lutz S, Berk L, Chang E, et al. American Society for Radiation Oncology (ASTRO): Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;79:965–976. DOI:10.1016/j.ijrobp.2010.11.026
  • Hahn C, Kavanagh B, Bhatnagar A, et al. Choosing wisely: the American Society for Radiation Oncology’s top 5 list. Pract Radiat Oncol. 2014;4:349–355. DOI:10.1016/j.prro.2014.06.003
  • Laugsand TS, Kaasa S, Romundstad P, et al. Radiotherapy for bone metastases: practice in Norway 1997-2007. A national registry-based study. Acta Oncol. 2013;52:1129–1136. DOI:10.3109/0284186X.2012.747697
  • Nieder C, Norum J, Spanne O, et al. Does distance to treatment centre influence the rate of palliative radiotherapy in adult cancer patients? Anticancer Res. 2009;29:2641–2644.
  • Lutz ST, Jones J, Chow E. Role of radiation therapy in palliative care of the patient with cancer. J Clin Oncol. 2014;32:2913–2919. DOI:10.1200/JCO.2014.55.1143
  • Bedard G, Hoskin P, Chow E. Overall response rates to radiation therapy for patients with painful uncomplicated bone metastases undergoing initial treatment and retreatment. Radiother Oncol. 2014;112:125–127. DOI:10.1016/j.radonc.2014.06.015
  • Oven Ustaalioglu BB, Balvan O, Bilici A, et al. The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival. Clin Transl Oncol. 2015;17:895–902. DOI:10.1007/s12094-015-1323-x
  • Gebhardt BJ, Rajagopalan MS, Gill BS, et al. Impact of dynamic changes to a bone metastases pathway in a large, integrated, National Cancer Institute-designated comprehensive cancer center network. Pract Radiat Oncol. 2015;5:398–405. DOI:10.1016/j.prro.2015.06.013
  • Rajagopalan MS, Flickinger JC, Heron DE, et al. Changing practice patterns for breast cancer radiation therapy with clinical pathways: an analysis of hypofractionation in a large, integrated cancer center network. Pract Radiat Oncol. 2015;5:63–69. DOI:10.1016/j.prro.2014.10.004